Biogen (BIIB) stock
Biogen technical analysis
Oscillators
Summary
Moving averages
| Oscillators | Value | Signal |
|---|---|---|
| RSI (14) | 54.49 | Neutral |
| Stochastic %K (14, 3, 3) | 49.59 | Neutral |
| CCI (20) | 18.22 | Neutral |
| ADX (14) | 22.88 | Neutral |
| Awesome Oscillator | 4.78 | Neutral |
| Momentum (10) | 4.52 | Buy |
| MACD (12, 26) | 2.51 | Sell |
| Stoch RSI (3, 3, 14, 14) | 20.12 | Neutral |
| Williams %R (14) | -43.4 | Neutral |
| Bull Bear Power | -4.033 | Sell |
| Ultimate Oscillator (7, 14, 28) | 48.7 | Neutral |
| Moving averages | Value | Signal |
|---|---|---|
| EMA (10) | $223.47 | Buy |
| SMA (10) | $225.48 | Sell |
| EMA (20) | $221.82 | Buy |
| SMA (20) | $220.69 | Buy |
| EMA (30) | $219.95 | Buy |
| SMA (30) | $220.48 | Buy |
| EMA (50) | $216.35 | Buy |
| SMA (50) | $215.72 | Buy |
| EMA (100) | $208.58 | Buy |
| SMA (100) | $207.58 | Buy |
| EMA (200) | $196.31 | Buy |
| SMA (200) | $195.45 | Buy |
| Ichimoku Base Line (9, 26, 52, 26) | $219.71 | Buy |
| VWMA (20) | $221.34 | Buy |
| Hull MA (9) | $221.23 | Buy |
Support & resistance levels
Resistance
- R1$230.49+3.09%Weak
Support
- S1$220.63-1.32%Strong
- S2$203.70-8.90%Strong
- S3$193.03-13.67%Strong
Levels are detected automatically from swing highs and lows on the daily chart and clustered by volatility (ATR). Strength reflects the number of times price reacted at each level.
| Pivot points (daily) | S3 | S2 | S1 | P | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | $214.16 | $216.99 | $218.43 | $221.26 | $222.70 | $225.53 | $226.97 |
| Fibonacci | $216.99 | $218.62 | $219.63 | $221.26 | $222.89 | $223.90 | $225.53 |
| Camarilla | $218.71 | $219.10 | $219.49 | $221.26 | $220.27 | $220.66 | $221.05 |
| Woodie | $213.47 | $216.64 | $217.75 | $220.91 | $222.02 | $225.18 | $226.29 |
| DeMark | — | — | $217.71 | $220.90 | $221.98 | — | — |
Biogen price forecast
| Horizon | Bear case (95%) | Low (68%) | Trend target | High (68%) | Bull case (95%) |
|---|---|---|---|---|---|
| 5 trading days | $203.50 | $213.87 | $224.77 +0.5% | $236.23 | $248.27 |
| 21 trading days | $186.47 | $206.46 | $228.60 +2.2% | $253.11 | $280.26 |
| 63 trading days | $167.91 | $200.31 | $238.96 +6.9% | $285.07 | $340.08 |
The technical bias for Biogen is bullish (overall rating: Buy).
Bullish scenario: a sustained break above $230.49 would open the way toward $242.01.
Bearish scenario: a daily close below $220.63 could extend the decline toward $203.70.
Statistical ranges are based on historical volatility and trend, not a guarantee of future prices. Not financial advice.
About Biogen
Biogen (BIIB) shares are trading at $223.59, up +1.69% today. The company belongs to the Health Care sector and has a market capitalization of $33.04B.
The stock’s 52-week range is $138.00 – $230.49, with a price-to-earnings ratio of 39.7. It has moved -1.22% over the past week and +3.14% over the past month.
On the daily chart the overall technical rating for Biogen is Buy, with the 14-day RSI at 54.5. The nearest support is at $220.63 and the nearest resistance at $230.49.
Related markets
AllStock market news
-
Asana, Zscaler, Appian, Atlassian, and Shopify Stocks Trade Up, What You Need To KnowYahoo Finance UK2 hr. ago
-
3 tactical chip stocks to buy ahead of earnings, according to GoldmanInvesting.com2 hr. ago
-
The hidden warning beneath record stock market highsFinancial Post3 hr. ago
-
Nasdaq notches record high close as investors focus on earnings By ReutersInvesting.com3 hr. ago